The pharmacologic treatment of the early phase of first-episode psychosis in youths

Canadian Journal of Psychiatry

Volumn 46, Issue 9, 2001, Pages 803-809

  Walter, Garry ^a   Wiltshire, Catherine ^a   Anderson, Josephine ^a   Storm, Victor ^a  

^a Rivendell Child & Adolescent Unit   (Australia)

Author keywords

Adolescence; Bipolar disorder; Early psychosis; First onset psychosis; Pharmacologic treatment; Prodrome; Schizophrenia

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CARBAMAZEPINE; CLOZAPINE; GABAPENTIN; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

CLINICAL TRIAL; DATA BASE; DIABETES MELLITUS; DRUG CHOICE; DRUG EFFICACY; DRUG SAFETY; EMBASE; HUMAN; HYPERPROLACTINEMIA; HYPERSALIVATION; JUVENILE; MEDLINE; NEUTROPENIA; OBESITY; ORTHOSTATIC HYPOTENSION; PSYCHOSIS; REVIEW; SEXUAL DYSFUNCTION; TACHYCARDIA; VOMITING;

EID: 0035688140     PISSN: 07067437     EISSN: None     Source Type: Journal    
DOI: 10.1177/070674370104600903     Document Type: Review

References (58)

1. The prevalence of prodromal symptoms of schizophrenia in adolescence: A preliminary survey
2. Evaluating the importance of reducing the duration of untreated psychosis
3. Early detection and intervention with schizophrenia: Rationale
4. The number needed to treat: A clinically useful measure of treatment effect
5. Update and recommendations for the use of antipsychotics in early-onset psychosis
6. A double-blind comparison of fluphenazine an haloperidol in outpatient schizophrenia children
7. Clinical comparison of thiothixene and thioridazine in schizophrenic adolescents
8. Children with schizophrenia: Diagnosis, phenomenology and pharmacotherapy
9. Antipsychotics in children and adolescents
10. Risperidone in the management of psychotic adolescents: An open trial
11. Risperidone in adolescents with schizophrenia: An open pilot study
12. Juvenile bipolar disorder
13. A randomized control trial of interventions in the prepsychotic phase of psychotic disorders
14. Risperidone and tardive dyskinesa
15. Case study: Risperidone-induced hepatotoxicity in pediatric patients
16. Risperidone side effects
17. Long-term management of schizophrenia. The role of new antipsychotics
18. Open-label olanzapine treatment in five preadolescent children
19. Childhood-onset schizophrenia: An open label study of olanzapine in adolescents
20. Body mass index increase of 58% associated with olanzapine
21. Atypical antipsychotic agents and diabetes mellitus
22. Olanzapine-induced elevation of plasma triglycerides levels
23. New drugs for the treatment of schizophrenia
24. An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia
25. Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia: A clinical case series
26. Clozapine treatment of children and adolescents: A four year follow-up
27. Clozapine: A novel antipsychotic agent
28. Childhood-onset schizophrenia: A double-blind clozapine-haloperidol comparison
29. Myocarditis and cardiomyopathy associated with clozapine
30. Clozapine and associated diabetes mellitus
31. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications
32. Quetiapine fumarate: Clinical effectiveness, tolerability and pharmacokinetics in psychotic adolescents
33. Effects of clozapine-quetiapine combination therapy on weight and glycaemic control
34. Special considerations: Use of lithium in children, adolescents, and elderly populations
35. Double blind and placebo controlled study of lithium for adolescent bipolar disorders with secondary substance dependency
36. Are childhood psychiatric histories of bipolar adolescence associated with family history, psychosis, and response to lithium treatment?
37. Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar illness: A naturalistic study
38. Lithium in hospitalized children at four and eight weeks: Mood, behaviour and cognitive defects
39. Cognitive effects of lithium carbonate and haloperidol in treatment resistant aggressive children
40. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder
41. Divalproex sodium treatment in late adolescent and young adult acute mania
42. Mixed mania: Diagnosis and treatment
43. Polycystic ovaries and in women taking valproate for epilepsy
44. Obesity and endocrine disorders in women taking valproate for epilepsy
45. Withdrawal of antiepileptic medication in children: Correlation of cognitive function and plasma concentration - The multicentre "Holmfrid" study
46. Cognitive side effects of anticonvulsants
47. Lithium associated cognitive and functional deficits reduced by a switch to divalproex sodium: A case series
48. Cutaneous reactions to anti-convulsant medications
49. Mood stabilizers in children and adolescents
50. A prognostic study of clinical dimensions in adolescent-onset psychoses
51. Antidepressant treatment of juvenile depression
52. A double-blind randomized placebo controlled trial of fluoxetine in depressed children and adolescents
53. Venlafaxine versus fluvoxamine in the treatment of delusional depression: A pilot double blind controlled study
54. Treating first episode psychosis with atypical antipsychotics